FAKTOR-OPTIONSSCHEIN - BAYER | Market Closed - Deutsche Boerse AG 15:39:54 2024-06-07 EDT | ||
| 19.61 EUR | +5.20% |
|
| Current month | +2.08% | ||
| 1 month | -5.81% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 19.61 | +5.20% |
| 24-06-06 | 18.64 | +7.06% |
| 24-06-05 | 17.41 | -5.33% |
| 24-06-04 | 18.39 | +2.74% |
| 24-06-03 | 17.9 | -6.82% |
Delayed Quote Deutsche Boerse AG
Last update June 07, 2024 at 03:39 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | 
Société Générale
|
| WKN | SH8L88 |
| ISIN | DE000SH8L887 |
| Date issued | 2022-04-12 |
| Strike | 66.57 € |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.13 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 66.89 € |
|---|---|
| Lowest since issue | 1.04 € |
| Spread | 0.21 € |
| Spread % | 1.04% |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
28.09
EUR
Average target price
36.18
EUR
Spread / Average Target
+28.81%
- Stock Market
- Certificates
- Certificat
